Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.18M Buy
32,539
+182
+0.6% +$21.3K 1.87% 14
2026
Q1
$3.89M Sell
32,357
-22
-0.1% -$2.54K 2% 12
2025
Q4
$3.41M Sell
32,379
-164
-0.5% -$15.4K 1.66% 16
2025
Q3
$2.73M Buy
32,543
+90
+0.3% +$7.41K 1.33% 20
2025
Q2
$2.57M Sell
32,453
-36
-0.1% -$2.86K 1.37% 18
2025
Q1
$2.92M Buy
32,489
+11,310
+53% +$1.06M 1.73% 15
2024
Q4
$2.11M Buy
21,179
+115
+0.5% +$11.9K 1.33% 19
2024
Q3
$2.39M Buy
21,064
+233
+1% +$27.7K 1.57% 14
2024
Q2
$2.58M Buy
20,831
+214
+1% +$27.6K 1.91% 12
2024
Q1
$2.72M Sell
20,617
-775
-4% -$95.5K 2.1% 10
2023
Q4
$2.33M Buy
+21,392
New +$2.22M 1.91% 10

Other funds holding MRK

Wynn Capital's MRK Position: Q2 2026 in Review

Wynn Capital increased its Merck (MRK) stake by 0.56% in Q2 2026, buying an estimated $21.3K and bringing the position to 32,539 shares worth $4.18M. The position accounts for 1.87% of the portfolio, ranked #14.

Wynn Capital first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Wynn Capital held 32,539 shares of Merck worth $4.18M as of Q2 2026.
  • Wynn Capital bought 182 Merck shares in Q2 2026, an estimated $21.3K.
  • Merck made up 1.87% of Wynn Capital's portfolio in Q2 2026, its #14 holding.
  • Wynn Capital first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wynn Capital's 13F filing for Q2 2026, filed 8 Jul 2026.